ProCE Banner Activity

An Expert’s Guide to EHA 2022: A Preview of the Top Abstracts

Conference Coverage
Clinical Thought
Get insights into key studies identified by experts that were presented at the 2022 EHA annual meeting. The CCO EHA Conference Coverage program will have the information you need to understand and integrate the latest oncology data into your clinical practice.

Released: June 20, 2022

Expiration: June 19, 2023

Share

Faculty

Jesus San-Miguel

Jesus San-Miguel, MD, PhD

Director of Clinical and Translational Medicine
Clinica Universidad de Navarra
Universidad de Navarra
Pamplona, Spain

Alessandra Tedeschi

Alessandra Tedeschi, MD

Consultant in Hematology
Division of Hematology
Niguarda Hospital
Milano, Italy

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

BeiGene, Ltd.

Jazz Pharmaceuticals, Inc.

Faculty Disclosure

Primary Author

Jesus San-Miguel, MD, PhD

Director of Clinical and Translational Medicine
Clinica Universidad de Navarra
Universidad de Navarra
Pamplona, Spain

Jesús F. San-Miguel, MD, PhD: consultant: AbbVie, Amgen, Bristol-Myers Squibb, Celgene, GlaxoSmithKline, Janssen, Karyopharm, MSD, Novartis, Regeneron, Roche, Sanofi, SecuraBio, Takeda.

Alessandra Tedeschi, MD

Consultant in Hematology
Division of Hematology
Niguarda Hospital
Milano, Italy

Alessandra Tedeschi, MD: consultant: AbbVie, AstraZeneca, BeiGene, Janssen.